Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Galle PR, Blessing M, Rose-John S, Neurath MF. TGF β suppresses tumor progression in Th2 colitis and as・・・. Immunity. 2004. 21, 491-501
Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A, Matsumoto T, Yamamura T, Azuma J, Nishimoto N, Yoshizaki K, Shimoyama T, Kishimoto T. A pilot randomized trial of a human anti-interleukln-6 receptor monoclonal antibody In active Crohn's disease. Gastroenterology. 2004. 126, 989-996
IL-6 and Crohn's disease. Curr. Drug. Targets. 2003. 2. 125-130
Histological change of the colon after anti-IL-6receptor therapy for Crohn's disease
2001 -
IL-6 アンタゴニストを有効成分として含有する炎症性腸疾患の予防又は治療剤(特許)
1998 -
Prevention and treatment of inflammatory bowel disease with IL-6 antagonists.
1998 -
Education (2):
- 1980 Osaka University Faculty of Medicine
- 1980 Osaka University Faculty of Medicine
Professional career (1):
M.D., Ph.D. (Osaka University)
Work history (2):
2003 - - 大阪大学 講師
2003 - - Osaka University, Instructor
Awards (2):
2002 - Gut Inflammation Front Line Meeting最優秀賞
2002 - Gut Inflammation Front Line Meeting First Prize
Association Membership(s) (12):
日本癌学会
, 日本臨床免疫学会
, 日本消化器免疫学会
, 米国免疫学会
, 米国消化器病学会
, 日本免疫学会
, 日本肝臓学会
, 日本消化器内視鏡学会
, 日本消化器病学会
, 日本内科学会
, The Japanese Cancer Association
, The Japan Society for Clinical Immunology